Evgen Pharma Share Price | |
---|---|
Price | 0.80 |
Bid | 0.75 |
Ask | 0.85 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.80 |
High | 0.80 |
Low | 0.80 |
Prev. Close | 0.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 427.35m |
Market Capitalisation | £3.42m |
Market Size | 30,000 |
52 Week High | 4.05 |
52 Week High Date | 10-May-2023 |
52 Week Low | 0.75 |
52 Week Low Date | 19-Apr-2024 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -0.544218 |
Earnings | -1.47 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
|
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
05-Apr-24 | 05-Apr-24 | Buy | Susan (Sue) Foden held the position of Interim Chairman at the time of this trade.Susan (Sue) Foden | 1.00 | GBX | 600,000 | 725,000 |
05-Apr-24 | 05-Apr-24 | Buy | Toni Hänninen held the position of CFO at the time of this trade.Toni Hänninen | 1.00 | GBX | 1,000,000 | 1,000,000 |
05-Apr-24 | 05-Apr-24 | Placing | Huw Jones held the position of CEO at the time of this trade.Huw Jones | 1.00 | GBX | 3,000,000 | 3,184,793 |
05-Apr-24 | 05-Apr-24 | Buy | Huw Jones held the position of CEO at the time of this trade.Huw Jones | 1.44 | GBX | 122,293 | 3,184,793 |
31-Mar-21 | 31-Mar-21 | Notification of Holding | Susan (Sue) Foden held the position of Non-Executive Director at the time of this trade.Susan (Sue) Foden | 0.00 | 0 | 125,000 |
Evgen Pharma is a clinical drug development company developing sulforaphane-based medicines focussed on the treatment of cancer and inflammation.